STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are... Copyright ©2025. All Rights Reserved.

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s BNT-327 in a deal possibly worth over $11 ...

Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate ...

Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug ...

The top 10 med-tech stock gainers and losers for the week.

A peptide with a dual mechanism of action – it dissolves the bacterial membrane and activates the immune system – could be an effective weapon against microorganisms that have evolved ways to evade ...

More phase III data coursed through the annual American Society of Clinical Oncology (ASCO) conference on Sunday, as ...

Several 5-HT4 receptor (5-HT4R) agonists are approved for treating chronic idiopathic constipation (CIC) by stimulating ...

The polarization of macrophages is crucial in modulating the tumor microenvironment and impacting cancer development. Long ...

Bronchodilators are front-line weapons against asthma and chronic obstructive pulmonary disorder. The search continues for ...

The Trump administration released its budget proposal for fiscal year 2026, which would chop roughly 40% from the NIH budget ...